Are immunoglobulin free light chains levels reliable to assess disease activity in rheumatoid arthritis?

被引：1
|
作者：
Djidjik, Reda [1 ]
Messaoudani, Nesrine [1 ]
Raaf, Nabil [1 ]
Boudjella, Mohammed Lotfi [1 ]
Abdessmed, Amina [3 ]
Bahaz, Naima [2 ]
Rahal, Fadia [3 ]
Ladjouze, Aicha [3 ]
Ghaffor, Mohammed [1 ]
机构：
[1] Beni Messous Teaching Hosp, Cent Lab Med Biol, Algiers, Algeria
[2] Beni Messous Teaching Hosp, Dept Rheumatol, Algiers, Algeria
[3] Specialized Med Ctr Ben Aknoun, Dept Rheumatol, Algiers, Algeria
来源：
JOINT BONE SPINE | 2013年 / 80卷 / 04期
关键词：
Rheumatoid arthritis; Immunoglobulin free light chains; DAS28; SYSTEMIC-LUPUS-ERYTHEMATOSUS; SERUM;
D O I：
10.1016/j.jbspin.2012.12.007
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：437 / 438
页数：3
相关论文
共 50 条
  • [1] Judging disease activity in rheumatoid arthritis by serum free kappa and lambda light chain levels
    Ye, Yun
    Li, Su-Liang
    Xie, Ming
    Jiang, Ping
    Liu, Kai-Ge
    Li, Ya-Jun
    KAOHSIUNG JOURNAL OF MEDICAL SCIENCES, 2013, 29 (10) : 547 - 553
  • [2] Elevation of Serum Immunoglobulin Free Light Chains During the Preclinical Period of Rheumatoid Arthritis
    Deng, Xiaoli
    Crowson, Cynthia S.
    Rajkumar, S. Vincent
    Dispenzieri, Angela
    Larson, Dirk R.
    Therneau, Terry M.
    Matteson, Eric L.
    Kyle, Robert A.
    Katzmann, Jerry A.
    Gabriel, Sherine E.
    Davis, John M., III
    JOURNAL OF RHEUMATOLOGY, 2015, 42 (02) : 181 - 187
  • [3] Decrease in immunoglobulin free light chains in patients with rheumatoid arthritis upon rituximab (anti-CD20) treatment correlates with decrease in disease activity
    Kormelink, T. Groot
    Tekstra, J.
    Thurlings, R. M.
    Boumans, M. H. J.
    Vos, K.
    Tak, P. P.
    Bijlsma, J. W. J.
    Lafeber, F. P. J. G.
    Redegeld, F. A.
    van Roon, J. A. G.
    ANNALS OF THE RHEUMATIC DISEASES, 2010, 69 (12) : 2137 - 2144
  • [4] Immunoglobulin free light chains in saliva: a potential marker for disease activity in multiple sclerosis
    Kaplan, B.
    Golderman, S.
    Ganelin-Cohen, E.
    Miniovitch, A.
    Korf, E.
    Ben-Zvi, I.
    Livneh, A.
    Flechter, S.
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2018, 192 (01) : 7 - 17
  • [5] Immunoglobulin free light chain levels and rituximab response in rheumatoid arthritis: Comment on the article by Sellam et al
    Tekstra, Janneke
    van Roon, Joel
    Kormelink, Tom Groot
    Redegeld, Frank
    ARTHRITIS AND RHEUMATISM, 2011, 63 (12): : 4034 - 4035
  • [6] Immunoglobulin Free Light Chains in the Pathogenesis of Lung Disorders
    Mortaz, Esmaeil
    Adcock, Ian M.
    Jamaati, Hamidreza
    Khosravi, Adnan
    Movassaghi, Masoud
    Garssen, Johan
    Mogadam, Mostafa Alavi
    Redegeld, Frank A.
    IRANIAN JOURNAL OF ALLERGY ASTHMA AND IMMUNOLOGY, 2017, 16 (04) : 282 - 288
  • [7] Association of Leptin Levels and Disease Activity in Patients with Early Rheumatoid Arthritis
    Taylan, Ali
    Akinci, Baris
    Toprak, Burak
    Birlik, Merih
    Arslan, Fatma Demet
    Ekerbicer, Hasan
    Gundogdu, Baris
    Colak, Ayfer
    Engin, Bahar
    ARCHIVES OF MEDICAL RESEARCH, 2021, 52 (05) : 544 - 553
  • [8] Methods used to assess remission and low disease activity in rheumatoid arthritis
    Ometto, Francesca
    Botsios, Costantino
    Raffeiner, Bernd
    Sfriso, Paolo
    Bernardi, Livio
    Todesco, Silvano
    Doria, Andrea
    Punzi, Leonardo
    AUTOIMMUNITY REVIEWS, 2010, 9 (03) : 161 - 164
  • [9] An Association between Neutrophils and Immunoglobulin Free Light Chains in the Pathogenesis of Chronic Obstructive Pulmonary Disease
    Braber, Saskia
    Thio, Marco
    Blokhttis, Bart R.
    Henricks, Paul A. J.
    Koelink, Pim J.
    Kormelink, Tom Groot
    Bezemer, Gillina F. G.
    Kerstjens, Huib A. M.
    Postma, Dirkje S.
    Garssen, Johan
    Kraneveld, Aletta D.
    Redegeld, Frank A.
    Folkerts, Gert
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2012, 185 (08) : 817 - 824
  • [10] A SIMPLE INDEX TO ASSESS DISEASE-ACTIVITY IN RHEUMATOID-ARTHRITIS
    SCOTT, DL
    JOURNAL OF RHEUMATOLOGY, 1993, 20 (03) : 582 - 584
12345